-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on CME Group, Raises Price Target to $300

Benzinga·06/04/2025 14:17:35
Listen to the news
Oppenheimer analyst Owen Lau maintains CME Group (NASDAQ:CME) with a Outperform and raises the price target from $282 to $300.